STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #1776 by analyst upside · 2026-06-27
QDEL
QuidelOrtho Corporation
Healthcare · Market Cap $940M · P/E 0x
ANALYST PRICE TARGET
+35.1%
implied upside to consensus target
Current Price $13.79
Consensus Target $18.62
Bull Target $38.0
Bear Target $11.0
Analysts Covering 4
ANALYST CONSENSUS - HOLD
Strong Buy
0
Buy
1
Hold
2
Sell
1
52-Week Low $9.92
52-Week High $35.58
YTD Return -52.1%
FUNDAMENTALS
Market Cap $940M
P/E Ratio (TTM) N/A
Forward P/E 5.6x
EPS (TTM) $-17.85
PEG Ratio 2.06
Dividend Yield N/A
Revenue (TTM) $2.7B
Profit Margin -45.6%
52-WEEK RANGE
52-Week Low $9.92
52-Week High $35.58
Current Price $13.79
Bear Target $11.0
Bull Target $38.0
● Now $13.79 ● Target $18.62
TRADING DATA
Avg Volume 2.3M
YTD Return -52.1%
Analyst Count 4
Consensus Hold
Upside to Target +35.1%
Last Updated 2026-06-27

ANALYST SUMMARY

QuidelOrtho Corporation (QDEL) is currently trading at $13.79 with a Wall Street consensus price target of $18.62, implying potential upside of 35.1% over the next 12 months. 4 analysts currently cover QDEL, with a consensus rating of Hold - 25% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $38.0, while the most cautious has a target of $11.0.

QDEL operates in the Healthcare sector with a market capitalisation of $940M. The stock is down 52.1% year-to-date and is currently trading near the lower end of its 52-week range of $9.92 – $35.58.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for QDEL, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Jefferies ↓ Downgrade
Buy → Hold 2026-05-07 50% win rate (6 calls)
Citigroup — Reiterated
Neutral → Neutral 2026-05-06 Building track record
UBS — Reiterated
Neutral → Neutral 2026-04-10 33% win rate (6 calls)
Citigroup — Reiterated
Neutral → Neutral 2026-02-12 Building track record
UBS — Reiterated
Neutral → Neutral 2026-01-21 33% win rate (6 calls)
JP Morgan — Reiterated
Underweight → Underweight 2025-11-07 43% win rate (7 calls)
UBS — Reiterated
Neutral → Neutral 2025-11-06 33% win rate (6 calls)
Citigroup ↓ Downgrade
Buy → Neutral 2025-10-07 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
14
out of 100
Coverage depth
12/30
Consensus clarity
0/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →